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Background/aim: To investigate the changes in the spleen size, parenchymal heterogeneity, and computed tomography (CT) texture
analysis features of patients diagnosed with Coronavirus disease 2019 (COVID-19)
Materials and methods: The size and parenchymal structure of the spleen in 91 patients who underwent thoracic CT examination due
to COVID-19 were evaluated. For the evaluation of parenchymal heterogeneity, CT texture analysis was performed using dedicated
software (Olea Medical, France). The texture analysis of each case consisted of 15 first-order intensity-based features, 17 gray level cooccurrence matrix-based features, and 9 gray level run length matrix-based features.
Results: A total of 91 patients (45 males, 46 females) with a mean age of 54.31 ± 16.33 years (range: 18–81) were included in the study. A
statistically significant decrease in spleen size was seen in the follow-up CT examinations (p < 0.001) whereas no statistically significant
difference was found between the Hounsfield unit (HU) values. The radiomics consisted of first-order intensity-based features such as
90th percentile, maximum, interquartile range, range, mean absolute deviation, standard deviation, and variance, all of which showed
statistically significant differences (p-values: < 0.001, < 0.001, 0.001, 0.003, 0.001, 0.001, and 0.004, respectively). “Correlation” as a
gray level co-occurrence matrix-based feature and “gray level nonuniformity” as a gray level run length matrix-based feature showed
statistically differences (p-values: 0.033 and < 0.001, respectively).
Conclusions: Although COVID-19 manifests with lung involvement in the early stage, it can also cause systemic involvement, and the
spleen may be one of its target organs. A decrease in the spleen size and parenchymal microstructure changes can be observed in the
short follow-up time. It is hoped that the changes in the parenchymal microstructure will be demonstrated by a noninvasive method:
texture analysis.
Key words: COVID-19, spleen size, texture analysis

1. Introduction
Coronavirus disease 2019 (COVID-19) has spread
fast from China and can now be found everywhere in
the world. Most of the patients have mainly displayed
pneumonia-associated symptoms such as fever, cough,
dyspnoea, and myalgia [1]. However, the disease may also
involve other organs, such as the gastrointestinal, nervous,
and cardiovascular systems [1,2]. It uses angiotensinconverting enzyme 2 (ACE2) as a host cell receptor
[3]. Li et al. [1] reported that the lungs had a moderate
expression of ACE2 among all the tissues in their study
whereas the spleen had the lowest ACE2 expression levels.
The spleen is the largest peripheral lymphoid organ in the
human body. It is the main site for immune responses
and immune cell placement, with blood filtering,

blood storage, hematopoietic, and immunomodulation
functions [2].
Computed tomography (CT) texture analysis is a
relatively new image post-processing technique that
uses mathematical methods to analyze the distribution
and arrangement of all the pixels in the medical images,
and has a series of quantitative features. First-order
characteristics such as intensity, heterogeneity, deviation,
and skewness from the pixel intensity histogram (expressed
in Hounsfield units, HU) and second-order characteristics
such as the gray level co-occurrence matrix (GLCM) and
the gray level run length matrix (GLRLM) parameters
describe the spatial relationship and characteristics of
the tissue voxels in greater detail [4]. They are commonly
used for the noninvasive characterization and grading of
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tumors. Texture analysis struggles to characterize complex
visual patterns by quantitatively identifying simpler but
characteristic subpatterns [5–7]. Image texture gives us
information about the spatial arrangement of intensities
in an image or selected region of an image. To analyze an
image texture in computer graphics, there are two ways
to approach the issue: structured approach and statistical
approach. A structured approach sees an image texture
as a set of primitive pixels in some regular or repeated
pattern. A statistical approach sees an image texture as a
quantitative measure of the arrangement of intensities in
a region [8]. The analysis provides information regarding
the periodicity of signal intensity patterns generated in
images of tissues. Alterations in these signal patterns
appear to correlate with histopathological changes in the
region of interest [9].
In this study, we investigated the changes in the spleen
size, HU density, and CT texture analysis features of
patients diagnosed with COVID-19.
2. Materials and methods
2.1. Patients
This retrospective study was approved by local ethics
committee and written informed consent was waived.
Between 21 March 2020 and 10 May 2020, 91 consecutive
patients with diagnosis of COVID -19, that was made by
positive test for COVID-19 viral RNA in nasopharyngeal
or oropharyngeal-swab specimens collected from patients
by real-time reverse transcription polymerase chain
reaction, was enrolled. COVID-19 positive patients with
at least two consecutive thoracic CT images, showing
imaging findings compatible with COVID-19 [10], were
included in the study. Exclusion criteria were; patients
with malignancy, chronic disease or hematological disease,
patients receiving hormone or immunosuppressive therapy
for any reasons, and severe motion artifact on chest CT.
2.2. CT technique
All patients underwent chest CT for lung parenchyma
evaluation, as a part of our hospital COVID-19 guidelines.
All chest CT acquisitions were performed with the
patients in supine position and with breath-holding
following inspiration, without contrast medium injection.
After obtaining a frontal scout view, lung scanning was
performed from the apex to the diaphragm using the
multislice computed tomography device with 16 detectors
[Somatom Emotion 16-slice; Siemens AG Berlin and
Munchen-Germany], dedicated only to patients with
COVID-19. The following technical parameters were used:
tube voltage: 110–120 kV; tube current modulation 100–
250 mAs; slice thickness: 3 mm; spiral pitch factor: 0.8.
Images were obtained with both mediastinal [width 350
HU; level 50 HU] and parenchymal [width 1400 HU; level
–600 HU] window settings. Because only more than half of

the spleen could be obtained from the images, the longest
axis of the spleen was taken as reference when calculating
its size. Since the imaging protocols were predetermined
for COVID-19 patients, the amount of spleen for the same
patient could be obtained similarly in all CT images.
2.3. Image analysis
A total of 91 patients were included in this study. The
thoracic CT examinations in our picture archiving and
communication system (PACS) archive were evaluated.
Two radiologists with approximately 10 years’ experience
each (AB, AK) reviewed the images independently, with
the final finding reached by consensus when there was a
discrepancy. In the early stages of the epidemic, serial CT
scans were performed in some patients, possibly due to
the changing clinical situation. We evaluated those who
had more than 4 (n = 50) thoracic CT examinations to
determine the change in the size of the spleen within 1 week
of the initial examination, within 2 weeks of it, and 2 weeks
after it. For those who had fewer than 4 examinations (n
= 41), the size of the spleen and the time interval between
the initial and the last thoracic CT examinations were
noted. If the time interval between the 2 CT examinations
was 1 week or less (31 of 91 patients), 2 weeks or less (36
of 91 patients), or more than 2 weeks (24 of 91 patients),
the specified time intervals were classified into groups 1, 2,
and 3, respectively.
In the axial CT examination, the longest axis of the
spleen was measured in the mediastinal window. Then, at
the slice level, where the spleen length was measured, HU
measurements were made with round ROIs, with the same
mm2 in the initial and last CT examinations. We measured
the HU values, which we evaluated to investigate the
structural change in the parenchyma, only in the first
and last CT examinations. We did this to observe the
ultimate change in the splenic parenchyma. The ROI areas
differed among the patients but were equally determined
in the initial and last CT examinations of the same patient.
The spleen diameters and HU values were compared to
determine if there was a significant difference between
them.
The degree of radiological involvement of the lung
parenchyma was also evaluated. Presence of groundglass opacities, presence of consolidation, presence of
nodules, and increased reticular interstitial thickness
or peribronchovascular thickness were considered
parenchymal involvement features. Each of the five
lung lobes per patient was assessed on the basis of the
following scale according to the distribution of the affected
parenchyma: 0 = normal; 1 = < 25% abnormality; 2 = 25%–
50% abnormality; 3 = 50%–75% abnormality; and 4 = >
75% abnormality. An overall lung “total severity score” was
reached by summing up the five lung lobe scores (range of
possible scores: 0–20) [11], and the difference between the

973

BATUR et al. / Turk J Med Sci
values in the initial and last CTs of the same patient was
evaluated.
After that, the DICOM data were transferred to a
dedicated workstation (Olea sphere v. 3 SP2, Olea Medical,
La Ciotat, France). Nonenhanced axial CT images were
used to calculate the texture analysis features. At the slice
level where the spleen length was measured, an ROI was
manually drawn to cover the entire spleen parenchyma on
the axial CT images (Figure 1). Care was taken not to extend
the ROI limits a few millimeters from the periphery of the
spleen parenchyma to avoid possible errors. The texture
analysis of each ROI consisted of 15 first-order intensitybased features (entropy, minimum, 10th percentile, 90th
percentile, maximum, mean, median, interquartile range,
range, mean absolute deviation, standard deviation,
skewness, kurtosis, variance, and uniformity), 17 gray level
co-occurrence matrix-based features (autocorrelation,
joint average, cluster prominence, contrast, correlation,
difference average, difference entropy, joint energy, joint
entropy, inverse difference moment, inverse difference,
inverse variance, maximum probability, sum average, and
sum entropy), and 9 gray level run length matrix-based
features (short-run emphasis, long-run emphasis, gray
level nonuniformity, run percentage, gray level variance,
run variance, run entropy, low gray level run emphasis,
high gray level run emphasis). The texture analysis features
obtained in the 2 CT examinations were compared to
determine if there was a significant difference between
them.
2.4. Statistical analysis
The Kolmogorov–Smirnov test was used to determine
the normal distribution of continuous variables.
Categorical variables were expressed as raw numbers and
quantitative variables were expressed as median [minmax] for nonnormalized variables and as mean ± SD for
normal distribution. Comparisons between groups were
performed using repeated-measures ANOVA, one way
ANOVA, Mann–Whitney’s U and Kruskal–Wallis tests
for quantitative variables, as appropriate. Dunn’s pairwise
comparison test was used after Kruskal–Wallis test and
Tukey test was used after multiple measures ANOVA for
further multiple comparisons with Bonferroni correction.
P-values inferior to 0.05 was accepted denoting statistical
significance. Statistical analysis was performed with SPSS
v. 23.
3. Results
A total of 91 patients (45 males, 46 females) with a mean
age of 54.31 ± 16.33 years (range: 18–81) were included in
the study. According to the grouping made on the basis
of the time interval between the two CT examinations,
there was no statistically significant difference between the
patients’ age and sex for all the 3 groups.
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Figure 1. Axial nonenhanced CT showing the region of interest
[ROI] was drawn manually to cover the entire spleen parenchyma.
Care was taken not to extend the ROI limits a few millimeters
from the periphery of the spleen parenchyma to avoid possible
errors.

The lung parenchymal involvement was graded as
stated in the methods section. The groups’ grades according
to the time interval between the CT examinations
were compared. There was heterogenity between the
groups, which shows that there was random distribution
(Figure 2). In the comparison between the first and last
CT examinations, lung involvement was found to be
progressive in 14 patients, regressive in 55 patients, and
stable in 22 patients. However, there was no statistically
significant difference between the three groups in the
groupings by time interval (Table 1).
The changes in the spleen parenchymal density and
spleen diameters between the two CT examinations
were evaluated. There was heterogeneity in and between
the groupings by time interval, which shows that there
was random distribution. The average density values
and diameters of the three groups between the two CT
examinations were not different (Table 1). There was no
statistically significant difference between the HU values.
However, there was a statistically significant decrease in
the spleen sizes (p < 0.001). The longest diameters of the
spleen at admission, within 1 week, within 2 weeks, and 2
weeks after the initial CT were 113.28 ± 19.07 mm, 107.56
± 19.61 mm, 103.68 ± 19.16 mm, and 101.06 ± 17.85
mm, respectively (Figure 3a-d). There was a statistically
significant decrease in spleen size over time (Figure 4a-e).
The radiomics (texture analysis) values of the initial
and last CT examinations obtained for the spleen
parenchyma are shown in Table 2. In the comparison
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Figure 2. Box plot comparing the groups made according to time interval between the initial and last CT examinations. The heterogenity
between groups supports that the distribution was made randomly.
Table 1. Distribution of spleen size and density and lung involvement scores between groups.

Spleen diameter[mm][mean
± SD]

Group 1 [n = 31]

Group 2 [n = 36]

Group 3 [n = 24]

p

Initial CT

113.2 ± 18.8

115.5 ± 19.1

110.2 ± 19.2

0.571

Last CT

108 ± 19.2

105.2 ± 19.2

98.9 ± 17.7

0.208

Diameter difference [mm] [median[min/max]]

5[–7/14]

9.5[–7/45]

12[–9/22]

0.001*

Spleen density [Hounsfield
unit][mean ± SD]

Initial CT

47.1 ± 5.6

46.8 ± 5.9

48.8 ± 5.3

0.378

Last CT

47.9 ± 5.1

49.4 ± 5.2

49.1 ± 5.5

0.499

Lung involvement degree
[0–20] [median[min/max]]

Initial CT

4[1/14]

5[1/19]

5[1/20]

0.641

Last CT

4[0/11]

5[0/17]

3[0/15]

0.195

*Diameter difference = Spleen diameter [initial CT] – spleen diameter [last CT].

between the two examinations, the radiomics consisting of
first-order intensity-based features such as 90th percentile,
maximum, interquartile range, range, mean absolute
deviation, standard deviation, and variance showed

statistically significant differences (p-values: < 0.001, <
0.001, 0.001, 0.003, 0.001, 0.001, and 0.004, respectively).
“Correlation” as a gray level co-occurrence matrix-based
feature and “gray level nonuniformity” as a gray level run
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Figure 3. Axial nonenhanced CT showing the longest diameter of the spleen at admission [a], within 1 week [b], within 2 weeks [c], and
2 weeks after [d] the initial CT, respectively.

length matrix-based feature showed statistically significant
differences between the initial and last CT exminations
(p-values: 0.033 and < 0.001, respectively). There were
no statistically significant differences in the other texture
features in the comparison of the initial and last CT
examination values.
4. Discussion
In this study, we observed that the spleen was also affected
in COVID-19 patients other than lung parenchymal
involvement. In addition to the reduction in spleen size,
we observed differences in texture analysis showing
microscopic changes, although there was no difference in
macroscopic observation.
In COVID-19 patients, it is claimed that the virus
may enter the peripheral blood from the lungs and
cause viremia. Then it attacks the targeting organs that
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express ACE2 such as spleen, testis, heart, colon, and liver
[1,12]. After the virus infects resident, infiltrating, and
circulating immune cells, the circulating immune cells
carry the virus to other organs. Once COVID-19 enters
the spleen, a series of immune responses are initiated
and multiple cytokines are released. Both virus and
autoimmunity damages the immune cells of the spleen,
peripheral and central lymph nodes, and other lymphoid
tissues [2,13,14]. In an autopsy study conducted in
patients who died due to COVID-19, it was reported
that the volume of the spleen decreased significantly [2].
Similar autopsy findings were reported in severe acute
respiratory syndrome [SARS] patients, too. Gu et al.
reported virus-infected immune cells in the circulating
blood, spleen, lymph nodes, and lymphoid tissue of
various organs in the autopsy samples. They reported the
presence of virus in most of the circulating lymphocytes

BATUR et al. / Turk J Med Sci

Figure 4. Histogram analysis showing the change in spleen size over time. The longest diameter of the spleen at admission [a], within
1 week [b], within 2 weeks [c], and 2 weeks after [d] the initial CT, respectively. [e] Profile plot showing the change in size-time curve.
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Table 2. First- and second-order texture analysis parameter values of spleen parenchyma in initial and last CT examinations.
First order

Initial CT

Last CT

p

Entropi

5.02[4.02/5.65]

5.00[4.47/5.57]

0.762

Minimum

–18[–154/22]

–27[–123/12]

0.064

10th percentile

27[–6/40]

24[–56/46]

0.212

90th percentile

66[55/108]

70[59/99]

0.001*

Maximum

108[70/218]

121[79/199]

0.001*

Mean

46.47[30.80/73.18]

48.02[14.79/66.13]

0.080

Median

46[30/73]

48[2/66]

0.168

Interquartile range

22[11/48]

25[13/101]

0.001*

Range

139[44/372]

149[68/292]

0.003*

Mean absolute deviation

13.43[4.62/29.12]

15.05[7.40/51.14]

0.001*

Standard deviation

16.91[7.34/36.94]

19.15[9.30/59.12]

0.001*

Skewness

0.001[–0.975/0.183]

-0.013[–0.371/0.287]

0.457

Kurtosis

3.17[2.8/9.5]

3.18[1.99/4.46]

0.092

Variance

286.08[53.81/1364.19]

366.89[86.5/524.044]

0.004*

Uniformity

0.037[0.029/0.074]

0.037[0.024/0.054]

0.517

Autocorrelation

1090.2[695.8/2165.9]

1127.5[706.0/1797.8]

0.962

Joint average

32.7[26.2/46.5]

33.2[26.4/42.3]

0.938

Cluster prominence

89869.5[17946.9/299918.1]

87344.4[25378.6/761017.8]

0.431

Cluster tendency

166.5[44.9/327.5]

165.3[80.4/634.8]

0.325

Contrast

90.2[20.9/152.1]

95.2[35.5/889.8]

0.153

Correlation

0.311[0.078/0.655]

0.279[0.072/0.894]

0.033*

Difference average

7.5[3.6/9.8]

7.6[4.7/9.5]

0.271

Difference entropy

4.3[3.3/40678]

4.3[3.7/9.7]

0.611

Difference variance

33.6[5.2/56.2]

35.1[13.2/53.7]

0.109

Joint energy

0.002[0.001/0.006]

0.002[0.001/0.003]

0.545

Joint entropy

9.7[7.8/10.1]

9.7[4.0/10.1]

0.774

Inverse difference moment

0.128[0.097/0.243]

0.124[0.100/0.190]

0.353

Inverse difference

0.216[0.179/0.336]

0.212[0.183/0.284]

0.317

Inverse variance

0.129[0.101/0.903]

0.128[0.102/0.199]

0.717

Maximum probability

0.005[0.003/0.017]

0.005[0.001/0.009]

0.362

Sum average

65.4[52.4/92.9]

66.5[52.8/84.6]

0.918

Sum entropy

5.7[6.7/6.2]

5.7[5.2/6.5]

0.225

Short run emphasis

0.966[0.472/0.978]

0.967[0.450/0.968]

0.092

Long run emphasis

1.1[0.3/1.3]

1.1[1.1/1.2]

0.175

Gray level nonuniformity

153.3[72.0/417.0]

131.1[34.5/386.5]

0.001*

Run persentage

0.955[0.911/0.970]

0.956[0.451/0.968]

0.133

Gray level variance

69.0[17.4/101.1]

65.6[30.7/168.7]

0.825

Run variance

0.051[0.032/0.107]

0.047[0.035/0.078]

0.051

Run entropy

5.3[4.5/5.6]

5.3[4.8/5.9]

0.852

Low gray level run emphasis

0.002[0.001/0.004]

0.002[0.001/0.004]

0.723

High gray level run emphasis

1138.4[752.7/2176.6]

1178.3[765.7/1819.7]

0.940

Gray level co-occurrence

Gray level run length matrix
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and lymphoid organs, and atrophy of spleen and lymph
nodes in patients with SARS [14].
To our knowledge, this is the first study that evaluates
spleen size and parenchyma structure with CT in
COVID-19 patients. In our study, it has been observed
that the spleen size of patients is reduced consistent
with the autopsy reports. In our evaluation of whether
the amount of lung parenchymal involvement affects
the change in the size of the spleen, we could not find a
significant relationship between the two parameters. We
observed a decrease in spleen size over time, regardless of
changes in the lung parenchyma. The size reduction in the
first 2 weeks [p < 0.001] was more significant than after
2 weeks [p = 0.003], although there was no statistically
difference. We think that the change in the size of the
spleen can be fully observed during long-term follow-up.
Although there was a significant reduction in the
size of the spleen, no significant difference was observed
in HU values which shows parenchymal heterogeneity
macroscopically. Whereas, it seems to us that we were
able to demonstrate the microscopic change in spleen
parenchyma through radiomics [texture analysis].
Texture analysis, a computer-assisted detection system,
aims to represent pixel distribution, intensities, and
dependences using mathematically defined parameters
and, thus, can quantitate tissue properties by featuring
the characteristics of the medical image [15]. It is
generally used at the level of research to demonstrate
tumor heterogeneity [16]. Tissue heterogeneity might
be associated with cellularity, proliferation, hypoxia,
angiogenesis, and necrosis [17]. As mentioned above,
both virus and autoimmunity damages the immune cells
of the spleen in COVID-19 patients. It seems to us that
the changes in texture analysis parameters were due to
cellular change and/or splenic parenchymal damage. We
think this may reflect microscopic changes in splenic
involvement in COVID-19 patients.
Our study has some limitations. Firstly, we do not have
spleen biopsy and hence histopathological data related
to involvement. For this reason, we could not reveal the
reasons that they may cause shrinkage in size and change
in texture analysis. Secondly, since the examinations were
directed to the lung, the spleen was not entirely within the
field of view. Therefore, volumetric measurement of the
spleen could not be made. Thirdly, all cases were COVID-19

positive in radiological imaging and laboratory tests at
the time of initial admission. Comparison with the predisease period could not be made since CT tests were not
available before involvement. Fourthly, because only the
lobar involvement amount was taken into account in the
scoring and each lobe was evaluated in quarter percentiles,
no significant changes were observed although there was
a change in the parenchymal involvement parameters and
amount. Therefore, lung parenchymal involvement score
and hence comparison with the change in the spleen was
not satisfactory. Fifthly, since imaging was not performed
to asymptomatic and clinically mild cases, possible splenic
effect could not be assessed in these patients. Finally, lack
of interobserver and intraobserver variability constitutes
the limitations of the study.
In conclusion, although COVID-19 manifests
itself with lung involvement in early period, it can also
cause systemic involvement and the spleen may be one
of the target organs. Decrease in the spleen size and
parenchymal microstructure changes can be observed in
a short follow-up time. It is hopeful that the changes in the
parenchymal microstructure may be demonstrated by a
noninvasive method, such as texture analysis. Long-term
changes in the spleen, shown to be affected in a short time
by COVID-19 and other possible systemic involvements,
should be kept under observation.
Conflict of interest
The author declare that they have no conflict of interest
Research involving human participants and/or animals
Ethical approval was waived by the local Ethics Committee
of Selcuk University in view of the retrospective nature of
the study and all the procedures being performed were
part of the routine care.
Informed consent
Informed consent was obtained from all individual
participants included in the study.
Informed consent
This retrospective study was approved by local ethics
committee at Selcuk University School of Medicine with
the decision numbered 2020/302 and written informed
consent was waived.

References
1.

Li M-Y, Li L, Zhang Y, Wang X-S. Expression of the SARSCoV-2 cell receptor gene ACE2 in a wide variety of human
tissues. Infectious Diseases of Poverty 2020; 9: 1-7. doi:
10.1186/s40249-020-00662-x

2.

Xu X, Chang X, Pan H, Su H, Huang B et al. Pathological
changes of the spleen in ten patients with new coronavirus
infection by minimally invasive autopsies. Chinese Journal of
Pathology 2020; 49: E014-E. doi: 10.1111/sji.12989

979

BATUR et al. / Turk J Med Sci
3.

Xu X, Chen P, Wang J, Feng J, Zhou H et al. Evolution of the
novel coronavirus from the ongoing Wuhan outbreak and
modeling of its spike protein for risk of human transmission.
Science China Life Sciences 2020; 63 (3): 457-460. doi: 10.1007/
s11427-020-1637-5

4.

Lin X, Xu L, Wu A, Guo C, Chen X et al. Differentiation of
intrapancreatic accessory spleen from small hypervascular
neuroendocrine tumor of the pancreas: textural analysis on
contrast-enhanced computed tomography. Acta Radiologica
2019; 60 (5): 553-560. doi: 10.1177/0284185118788895

5.

6.

10.

Yuan M, Yin W, Tao Z, Tan W, Hu Y. Association of radiologic
findings with mortality of patients infected with 2019 novel
coronavirus in Wuhan, China. Plos One 2020; 15 (3): e0230548.
doi: 10.1371/journal.pone.0230548

11.

Bernheim A, Mei X, Huang M, Yang Y, Fayad ZA et al.
Chest CT findings in coronavirus disease-19 (COVID-19):
relationship to duration of infection. Radiology 2020; 295 (3):
200463. doi: 10.1148/radiol.2020200463

12.

Davnall F, Yip CS, Ljungqvist G, Selmi M, Ng F et al.
Assessment of tumor heterogeneity: an emerging imaging tool
for clinical practice? Insights into Imaging 2012; 3 (6): 573-589.
doi: 10.1007/s13244-012-0196-6

Letko M, Marzi A, Munster V. Functional assessment of cell
entry and receptor usage for SARS-CoV-2 and other lineage B
betacoronaviruses. Nature Microbiology 2020; 5 (4): 562-569.
doi: 10.1038/s41564-020-0688-y

13.

Ramkumar S, Ranjbar S, Ning S, Lal D, Zwart C et al. MRIbased texture analysis to differentiate sinonasal squamous
cell carcinoma from inverted papilloma. American Journal
of Neuroradiology 2017; 38 (5): 1019-1025. doi: 10.3174/ajnr.
A5106

Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q et al. Clinical
characteristics of coronavirus disease 2019 in China. New
England Journal of Medicine 2020; 382 (18): 1708-1720. doi:
10.1056/NEJMoa2002032

14.

Gu J, Gong E, Zhang B, Zheng J, Gao Z et al. Multiple organ
infection and the pathogenesis of SARS. The Journal of
Experimental Medicine 2005; 202 (3): 415-424. doi: 10.1084/
jem.20050828

15.

Liu J, Mao Y, Li Z, Zhang D, Zhang Z et al. Use of texture
analysis based on contrast-enhanced MRI to predict treatment
response to chemoradiotherapy in nasopharyngeal carcinoma.
Journal of Magnetic Resonance Imaging 2016; 44 (2): 445-455.
doi: 10.1002/jmri.25156

16.

Zhang L, Zhou H, Gu D, Tian J, Zhang B et al. Radiomic
nomogram: pretreatment evaluation of local recurrence in
nasopharyngeal carcinoma based on MR imaging. Journal of
Cancer 2019; 10 (18): 4217. doi: 10.7150/jca.33345

17.

Ganeshan B, Goh V, Mandeville H, Ng Q, Hoskin P et al. CT
of non-small cell lung cancer: histopathological correlates for
texture parameters. Radiology 2013; 266: 326-336

7.

Choi JY. Radiomics and deep learning in clinical imaging: what
should we do? Nuclear Medicine and Molecular Imaging 2018;
52: 89-90. doi: 10.1007/s13139-018-0514-0

8.

Konstantin T, Katarina A, Galina P, Daniel G. Out-of-focus
region segmentation of 2D surface images with the use of
texture features. Journal Scientific and Technical of Information
Technologies, Mechanics and Optics 2015; 99 (5): 796-802. doi:
10.17586/2226-1494-2015-15-5-796-802

9.

980

Jafari-Khouzani K, Elisevich K, Patel S, Smith B, SoltanianZadeh H. FLAIR signal and texture analysis for lateralizing
mesial temporal lobe epilepsy. Neuroimage 2010; 49 (2): 15591571. doi: 10.1016/j.neuroimage.2009.08.064

